Antigua and Barbuda - Re-Export of Penicillins or Streptomycins Not in Dosage Forms
At $56 in 2014, the country was ranked number 12 among other countries in Re-Export of Penicillins or Streptomycins Not in Dosage Forms. New Zealand topped the ranking with $476,039.52 in 2019, -2.3% compared to 2018. Saudi Arabia, United States and United Arab Emirates respectively ranked number 2, 3 and 4 in this ranking. Guyana witnessed the best average annual growth at +152% per year, while United States witnessed the worst performance at -33% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2014 | 56.00 |
| 2013 | |
| 2012 | 93.00 |
| 2011 | |
| 2010 |
Download all data from 1999 to 2014
How does Antigua and Barbuda rank in Re-Export of Penicillins or Streptomycins Not in Dosage Forms?
| # | 12 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
New Zealand
|
476,039.52 | 2019 | -2.3 % | -7.7 % | View data | |
| 2 |
#2
Saudi Arabia
|
205,021.02 | 2018 | -57.1 % | -28.7 % | View data | |
| 11 |
#11
Trinidad and Tobago
|
82.00 | 2015 | NA | NA | View data | |
| 12 |
#12
Antigua and Barbuda
|
56.00 | 2014 | NA | NA | View data | |